FerranFeceCruz Profile Banner
Ferran Fece de la Cruz Profile
Ferran Fece de la Cruz

@FerranFeceCruz

Followers
584
Following
19K
Media
63
Statuses
1K

Cancer researcher, Catalan, Instructor at @MGHCancerCenter & @harvardmed #CorcoranLab PhD in Malignant Diseases at @CeMM_News (Vienna) & @Ludwig_Cancer (Oxford)

Boston, MA
Joined April 2015
Don't wanna be here? Send us removal request.
@FerranFeceCruz
Ferran Fece de la Cruz
2 years
Happy to report that we have identified secondary PIK3CA mutations as a novel mechanism of resistance to orthosteric PI3Kα inhibitors in breast cancer patients! @CD_AACR @MGHCancerCenter @harvardmed #CorcoranLab #Alpelisib #Inavolisib #bcsm.
1
9
28
@FerranFeceCruz
Ferran Fece de la Cruz
3 days
🙌🏼🙌🏼🙌🏼.
Tweet media one
0
0
3
@grok
Grok
1 day
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
505
645
5K
@FerranFeceCruz
Ferran Fece de la Cruz
9 days
🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️.
Tweet card summary image
oncologypipeline.com
Tiragolumab failed the Skyscraper-14 and 03 studies, Roche quietly reveals.
0
0
0
@FerranFeceCruz
Ferran Fece de la Cruz
1 month
RT @Cancer_Cell: Online Now: TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak https….
0
14
0
@FerranFeceCruz
Ferran Fece de la Cruz
1 month
Very interesting letter to the editor complementing our study published early this year in @Annals_Oncology comparing established resistance mechanisms to KRASG12C-i and the newly reported #daraxonrasib (pan-RAS inhibitor) resistance patters in PDAC @VHIO .
Tweet media one
0
2
9
@FerranFeceCruz
Ferran Fece de la Cruz
1 month
Tweet card summary image
catalonia.com
0
0
0
@FerranFeceCruz
Ferran Fece de la Cruz
1 month
RT @OncLive: RLY-2608 plus fulvestrant displayed a tolerable safety profile and preliminary activity in patients with PIK3CA-mutated, HR+/H….
Tweet card summary image
onclive.com
Sarah Sammons, MD, discusses data from the phase 1 ReDiscover trial of RLY-2608 plus fulvestrant in HR-positive, HER2-negative breast cancer.
0
8
0
@FerranFeceCruz
Ferran Fece de la Cruz
2 months
RT @NatureAging: 🗞️Our June issue is live!📷 This month, we're featuring work on editing epigenetic age, somatic mutation, senescence, Alzhe….
0
65
0
@FerranFeceCruz
Ferran Fece de la Cruz
2 months
🤦🏻‍♂️.
@lab_oren
Oren Schuldiner's Lab
2 months
My lab was totally destroyed tonight by an Iranian missile. Nobody was hurt. Flies, plasmids, cells, equipment - all gone. Heart breaking. If during the course of the past 16 years, you have received something from my lab - please keep them safe.
0
0
0
@FerranFeceCruz
Ferran Fece de la Cruz
2 months
RT @hospitalclinic: 🗣️ “Les cremades solars a la infància són el càncer del futur”. Pel Dia Europeu de la Prevenció del #CàncerDePell recor….
0
6
0
@FerranFeceCruz
Ferran Fece de la Cruz
2 months
RT @MGBResearchNews: In a new study, researchers from @MGHCancerCenter and colleagues found a new drug combo increased overall survival in….
0
1
0